Compare The Vita Coco Company Inc (COCO) vs Procter & Gamble Co (PG) Price & Performance

The Vita Coco Company (COCO) trades at $62.25, down 2.92% over 24 hours, with a bullish technical signal driven by oversold RSI readings and support near $62. Fundamentally, Q2 2026 earnings beat expectations with EPS of $0.82 versus $0.56 estimated, while revenue grew 28% year-over-year to $216 million. The company raised full-year 2026 guidance, reflecting strong demand and the Copra acquisition.

Outlook remains positive with 60% analyst buy ratings and an $80.67 consensus price target, implying ~30% upside. Key risks include margin pressure from rising costs and capacity constraints. Growth catalysts include international expansion and health-focused innovation in the beverage sector.

Procter & Gamble (PG) trades at $144.84, down 0.64% over 24 hours, with a bearish technical signal from moving averages but neutral oscillators. The company reported strong earnings beats in recent quarters, with Q3 2026 EPS expected at $1.90. Fundamentals show robust profitability, including an 18.44% net income margin and 30.13% ROE, though valuation ratios like P/E of 22.12 and P/S of 4.08 are at premiums. Recent news highlights a WNBA partnership and a rejected mini-tender offer, while cash flow trends indicate stable operations.

PG offers a stable outlook with consistent dividend growth and efficient supply chain improvements, but faces risks from premium valuations and soft demand concerns. Analyst consensus is bullish with a $161.20 price target, though near-term upside may be limited by economic headwinds. Investment appeal lies in its defensive qualities and dividend reliability, balanced against competitive and margin pressures.